Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02175108 · ClinicalTrials.gov registry record
Diet and Activity in Cerebral Palsy
A clinical trial, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- 47
- Enrollment target
NCT02175108: Completed study, sponsored by Shirley Ryan AbilityLab.
NCT02175108 is a clinical trial that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02175108 has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
This study aims to fill a gap in the literature, identify relevant clinical measures, and provide insight into the independent modifiable risk factors of obesity in the CP population with the long-term goal of improving screening, management and prevention of obesity in this at-risk and underserved population.
Primary Outcome
Subjects will complete dietary recall and total calories per day will be calculated
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-03 |
What the finished NCT02175108 record still lists
NCT02175108 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02175108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02175108 about?
NCT02175108 is a clinical study titled "Diet and Activity in Cerebral Palsy". This study aims to fill a gap in the literature, identify relevant clinical measures, and provide insight into the independent modifiable risk factors of obesity in the CP population with the long-term goal of improving screening, management and prevention of obesity in this at-risk and underserved ...
What is the current status of trial NCT02175108?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2014-06. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT02175108?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia